Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

KORU Medical Systems (KRMD) EPS (Weighted Average and Diluted) (2020 - 2025)

KORU Medical Systems has reported EPS (Weighted Average and Diluted) over the past 10 years, most recently at -$0.11 for Q4 2025.

  • Quarterly results put EPS (Weighted Average and Diluted) at -$0.11 for Q4 2025, up 52.17% from a year ago — trailing twelve months through Dec 2025 was -$0.06 (up 57.14% YoY), and the annual figure for FY2025 was -$0.06, up 53.85%.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$0.11 at KORU Medical Systems, down from $0.02 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for KRMD hit a ceiling of $0.04 in Q1 2024 and a floor of -$0.23 in Q4 2024.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was -$0.03 (2021), compared with a mean of -$0.04.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): plummeted 400.0% in 2021 and later skyrocketed 200.0% in 2024.
  • KORU Medical Systems' EPS (Weighted Average and Diluted) stood at -$0.02 in 2021, then plummeted by 100.0% to -$0.04 in 2022, then crashed by 300.0% to -$0.16 in 2023, then tumbled by 43.75% to -$0.23 in 2024, then skyrocketed by 52.17% to -$0.11 in 2025.
  • The last three reported values for EPS (Weighted Average and Diluted) were -$0.11 (Q4 2025), $0.02 (Q3 2025), and -$0.0 (Q2 2025) per Business Quant data.